Novartis Issues $120M Drug Recall, Plant Suspension
Novartis Consumer Health Inc. recalled several popular over-the-counter drugs and suspended operations at a Nebraska facility Sunday following consumer complaints about damaged pills, inconsistent packaging and mixed tablets, taking a $120...To view the full article, register now.
Already a subscriber? Click here to view full article